CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer

Tumori

Volumn 98, Issue 2, 2012, Pages 243-251

  Tunca, Berrin ^a   Egeli, Unal ^a   Cecener, Gulsah ^a   Tezcan, Gulcin ^a   Gokgoz, Sehsuvar ^a   Tasdelen, Ismet ^a   Bayram, Nuran ^a   Tolunay, Sahsine ^a   Umut, Gorkem ^a   Demirdogen, Elif ^a   Erturk, Elif ^a   Ak, Secil ^a   Cetintas, Sibel ^a   Evrensel, Turkkan ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Breast cancer; Circulating tumor cells; Prognosis

Indexed keywords

CYTOKERATIN 19; CYTOKERATIN 20; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MESSENGER RNA; TUMOR MARKER; ERBB2 PROTEIN, HUMAN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD SAMPLING; BREAST CARCINOMA; CANCER PROGNOSIS; CONTROLLED STUDY; CYTOKERATIN 19 GENE; CYTOKERATIN 20 GENE; EPIDERMAL GROWTH FACTOR RECEPTOR GENE; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ONCOGENE; ONCOGENE NEU; PRIMARY TUMOR; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL; BLOOD; BREAST TUMOR; CANCER GRADING; CANCER STAGING; CHEMISTRY; DISEASE FREE SURVIVAL; EARLY DIAGNOSIS; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RISK; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; TUMOR EMBOLISM;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DISEASE-FREE SURVIVAL; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATIN-19; KERATIN-20; LOGISTIC MODELS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RNA, MESSENGER; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84864881515     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161209800211     Document Type: Article

References (56)

1. Republic of Turkey Health Statistics, Turkish Ministry of Health. Available at http://www.saglik.gov.tr/
2. Ghossein RA, Bhattacharya S: Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours. Eur J Cancer, 36: 1681-1694, 2000. (Pubitemid 30616372)
3. Tsouma A, Aggeli C, Pissimissis N, Lembessis P, Zografos GN, Koutsilieris M: Circulating tumor cells in colorectal cancer: detection methods and clinical significance. Anticancer Res, 28: 3945-3960, 2008.
4. Khair G, Monson JR, Greenman J: Epithelial molecular markers in the peripheral blood of patients with colorectal cancer. Dis Colon Rectum, 50: 1188-1203, 2007. (Pubitemid 47087460)
5. Zieglschmid V, Hollmann C, Böcher O: Detection of disseminated tumor cells in peripheral blood. Crit Rev Clin Lab Sci, 42: 155-196, 2005. (Pubitemid 41647727)
6. Gervasoni A, Monasterio Muñoz RM, Wengler GS, Rizzi A, Zaniboni A, Parolini O: Molecular signature detection of circulating tumor cells using a panel of selected genes. Cancer Lett, 263: 267-279, 2008.
7. Hildebrandt M, Mapara MY, Körner IJ, Bargou RC, Moldenhauer G, Dörken B: Reverse transcriptase-polymerase chain reaction (RT-PCR)-controlled immunomagnetic purging of breast cancer cells using the magnetic cell separation (MACS) system: a sensitive method for monitoring purging efficiency. Exp Hematol, 25: 57-65, 1997. (Pubitemid 27063745)
8. Leitzel K, Lieu B, Curley E, Smith J, Chinchilli V, Rychlik W, Lipton A: Detection of cancer cells in peripheral blood of breast cancer patients using reverse transcription-polymerase chain reaction for epidermal growth factor receptor. Clin Cancer Res, 4: 3037-3043, 1998. (Pubitemid 29001479)
9. Gradilone A, Gazzaniga P, Silvestri I, Gandini O, Trasatti L, Lauro S, Frati L, Aglianò AM: Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease. Oncol Rep, 10: 217-222, 2003.
10. Tsouma A, Aggeli C, Lembessis P, Zografos GN, Korkolis DP, Pectasides D, Skondra M, Pissimissis N, Tzonou A, Koutsilieris M: Multiplex RT-PCR-based detections of CEA, CK20 and EGFR in colorectal cancer patients. World J Gastroenterol, 16: 5965-5974, 2010.
11. Coussens L, Yang-Feng TL, Lioa YC, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, Levison A, Ulrich A: Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science, 230: 1132-1139, 1985. (Pubitemid 16169997)
12. Schechter AL, Stern DF, Vaidyanathan L, Decker SJ, Drebin JA, Greene MI, Weinberg AR: The neu oncogene: an erbB related gene encoding a 185,000-Mr tumour antigen. Nature, 312: 513-516, 1984. (Pubitemid 15182278)
13. Slamon DJ, Goldolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF: Studies of the HER-2/neu proto-oncogene in human breast cancer and ovarian cancer. Science, 244: 707-712, 1989. (Pubitemid 19147683)
14. Fehm T, Müller V, Aktas B, Janni W, Schneeweiss A, Stickeler E, Lattrich C, Löhberg CR, Solomayer E, Rack B, Riethdorf S, Klein C, Schindlbeck C, Brocker K, Kasimir-Bauer S, Wallwiener D, Pantel K: HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial. Breast Cancer Res Treat, 124: 403-412, 2010.
15. Fuchs E, Weber K: Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem, 63: 345-382, 1994.
16. Taylor-Papadimitriou J, Berdichevsky F, D'Souza B, BurchellJ: Human models of breast cancer. Cancer Surv, 16: 59-78, 1993. (Pubitemid 23268912)
17. Nagaiah G, Abraham J: Circulating tumor cells in the management of breast cancer. Clin Breast Cancer, 10: 209-216, 2010.
18. Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R, Hoon DS: Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol, 16: 2632-2640, 1998. (Pubitemid 28363026)
19. Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B, Selby P: Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer, 71: 278-281, 1995.
20. Wong SC, Chan CM, Ma BB, Hui EP, Ng SS, Lai PB, Cheung MT, Lo ES, Chan AK, Lam MY, Au TC, Chan AT: Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients. Clin Cancer Res, 15: 1005-1012, 2009.
21. Miettinen M: Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod. Pathol, 8: 384-388, 1995.
22. Hu XC, Chow LW: Detection of circulating breast cancer cells with multiple-marker RT-PCR assay. Anticancer Res, 21: 421-424, 2001.
23. Leather AJ, Gallegos NC, Kocjan G, Savage F, Smales CS, Hu W, Boulos PB, Northover JM, Phillips RK: Detection and enumeration of circulating tumour cells in colorectal cancer. Br J Surg, 80: 777-780, 1993. (Pubitemid 23197741)
24. Chen YH, Gao W, Zhou T, Zhao W, Zhao H, Liu D, Felber E: Detection of bone marrow micrometastasis. Hybridoma, 18: 465-466, 1999.
25. Zhao S, Liu Y, Zhang Q, Li H, Zhang M, Ma W, Zhao W, Wang J, Yang M: The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature. Breast Cancer Res Treat, 130: 809-816, 2011.
26. Kahn HJ, Yang LY, Blondal J, Lickley L, Holloway C, Hanna W, Narod S, McCready DR, Seth A, Marks A: RTPCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters. Breast Cancer Res Treat, 60: 143-151, 2000. (Pubitemid 30307474)
27. Stathopoulou A, Vlachonikolis I, Mavroudis D, Perraki M, Kouroussis Ch, Apostolaki S, Malamos N, Kakolyris S, Kotsakis A, Xenidis N, Reppa D, Georgoulias V: Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J Clin Oncol, 20: 3404- 3412, 2002.
28. Xenidis N, Vlachonikolis I, Mavroudis D, Perraki M, Stathopoulou A, Malamos N, Kouroussis C, Kakolyris S, Apostolaki S, Vardakis N, Lianidou E, Georgoulias V: Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer. Ann Oncol, 14: 849-855, 2003. (Pubitemid 36827199)
29. Jotsuka T, Okumura Y, Nakano S, Nitta H, Sato T, Miyachi M, Suzumura K, Yamashita J: Persistent evidence of circulating tumor cells detected by means of RT-PCR for CEA mRNA predicts early relapse: a prospective study in nodenegative breast cancer. Surgery, 135: 419-426, 2004. (Pubitemid 38453497)
30. Ntoulia M, Stathopoulou A, Ignatiadis M, Malamos N, Mavroudis D, Georgoulias V, Lianidou ES: Detection of mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR. Clin Biochem, 39: 879-887, 2006. (Pubitemid 44363084)
31. Chen CC, Chang TW, Chen FM, Hou MF, Hung SY, Chong IW, Lee SC, Zhou TH, Lin SR: Combination of multiple mRNA markers (PTTG1, survivin, UbcH10 and TK1) in the diagnosis of Taiwanese patients with breast cancer by membrane array. Oncology, 70: 438-446, 2006.
32. Xenidis N, Perraki M, Kafousi M, Apostolaki S, Bolonaki I, Stathopoulou A, Kalbakis K, Androulakis N, Kouroussis C, Pallis T, Christophylakis C, Argyraki K, Lianidou ES, Stathopoulos S, Georgoulias V, Mavroudis D: Predictive and prognostic value of peripheral blood cytokeratin-19 mRNApositive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients. J Clin Oncol, 24: 3756-3762, 2006. (Pubitemid 46622314)
33. Xenidis N, Markos V, Apostolaki S, Perraki M, Pallis A, Sfakiotaki G, Papadatos-Pastos D, Kalmanti L, Kafousi M, Stathopoulos E, Kakolyris S, Mavroudis D, Georgoulias V: Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer. Ann Oncol, 18: 1623- 1631, 2007.
34. Ignatiadis M, Xenidis N, Perraki M, Apostolaki S, Politaki E, Kafousi M, Stathopoulos EN, Stathopoulou A, Lianidou E, Chlouverakis G, Sotiriou C, Georgoulias V, Mavroudis D: Different prognostic value of cytokeratin-19 mRNA-positive circulating tumor cells according to estrogen receptor andHER2 status in early stage breast cancer. J Clin Oncol, 25: 5194-5202, 2007. (Pubitemid 350232250)
35. Ignatiadis M, Perraki M, Apostolaki S, Politaki E, Xenidis N, Kafousi M, Stathopoulos E, Lianidou E, Sotiriou C, Georgoulias V, Mavroudis D: Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer. Clin Breast Cancer, 7: 883-889, 2007.
36. Ignatiadis M, Kallergi G, Ntoulia M, Perraki M, Apostolaki S, Kafousi M, Chlouverakis G, Stathopoulos E, Lianidou E, Georgoulias V, Mavroudis D: Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer. Clin Cancer Res, 14: 2593-2600, 2008.
37. Apostolaki S, Perraki M, Kallergi G, Kafousi M, Papadopoulos S, Kotsakis A, Pallis A, Xenidis N, Kalmanti L, Kalbakis K, Agelaki S, Kalykaki A, Stournaras C, Stathopoulos E, Georgoulias V, Mavroudis D: Detection of occult HER2 mRNApositive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance. Breast Cancer Res Treat, 117: 525-534, 2009.
38. Xenidis N, Ignatiadis M, Apostolaki S, Perraki M, Kalbakis K, Agelaki S, Stathopoulos EN, Chlouverakis G, Lianidou E, Kakolyris S, Georgoulias V, Mavroudis D: Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer. J Clin Oncol, 27: 2177-2184, 2009.
39. Chen Y, Zou TN, Wu ZP, Zhou YC, Gu YL, Liu X, Jin CG, Wang XC: Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer. Int J Biol Markers, 25: 59-68, 2010.
40. Suchy B, Austrup F, Driesel G, Eder C, Kusiak I, Uciechowski P, Grill HJ, Giesing M: Detection of mammaglobin expressing cells in blood of breast cancer patients, Cancer Lett, 158: 171-178, 2000.
41. Lin YC, Chen SC, Hsueh S, Lo YF, Chow-Wu YH, Liaw IC, Cheng AJ: Lack of correlation between expression of human mammaglobin mRNA in peripheral blood and known prognostic factors for breast cancer patients. Cancer Sci, 94: 99-102, 2003. (Pubitemid 36575866)
42. Benoy IH, Elst H, Philips M, Wuyts H, Van Dam P, Scharpé S, Van Marck E, Vermeulen PB, Dirix LY: Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer. Br J Cancer, 13: 672-680, 2006. (Pubitemid 43361898)
43. Marques AR, Teixeira E, Diamond J, Correia H, Santos S, Neto L, Ribeiro M, Miranda A, Passos-Coelho JL: Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence. Breast Cancer Res Treat, 114: 223-232, 2009.
44. Daskalaki A, Agelaki S, Perraki M, Apostolaki S, Xenidis N, Stathopoulos E, Kontopodis E, Hatzidaki D, Mavroudis D, Georgoulias V: Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer. Br J Cancer, 101: 589-597, 2009.
45. Grünewald K, Haun M, Urbanek M, Fiegl M, Müller-Holzner E, Gunsilius E, Dünser M, Marth C, Gastl G: Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth- factor receptor and cytokeratin-19. Lab Invest, 80: 1071-1077, 2000. (Pubitemid 30483225)
46. Liu Z, Fusi A, Schmittel A, Tinhofer I, Schneider A, Keilholz U: Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabine. Cancer Biol Ther, 10: 860-864, 2010.
47. Punnoose EA, Atwal SK, Spoerke JM, Savage H, Pandita A, Yeh RF, Pirzkall A, Fine BM, Amler LC, Chen DS, Lackner MR: Molecular biomarker analyses using circulating tumor cells. PLoS One, 5: e12517, 2010.
48. Hauch S, Zimmermann S, Lankiewicz S, Zieglschmid V, Böcher O, Albert WH: The clinical significance of circulating tumour cells in breast cancer and colorectal cancer patients. Anticancer Res, 27(3A): 1337-1341, 2007. (Pubitemid 46807280)
49. Van der Auwera I, Peeters D, Benoy IH, Elst HJ, Van Laere SJ, Prové A, Maes H, Huget P, van Dam P, Vermeulen PB, Dirix LY: Circulating tumour cell detection: a direct comparison between the Cell Search System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer. Br J Cancer, 102: 276-284, 2010.
50. Mikhitarian K, Martin RH, Ruppel MB, Gillanders WE, Hoda R, Schutte del H, Callahan K, Mitas M, Cole DJ: Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study. BMC Cancer, 8: 55-66, 2008.
51. Antolovic D, Galindo L, Carstens A, Rahbari N, Büchler MW, Weitz J, Koch M: Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies. BMC Biotechnol, 10: 35, 2010.
52. Molnar B, Floro L, Sipos F, Toth B, Sreter L, Tulassay Z: Elevation in peripheral blood circulating tumor cell number correlates with macroscopic progression in UICC stage IV colorectal cancer patients. Dis Markers, 24: 141-150, 2008. (Pubitemid 352038622)
53. Cohen SJ, Alpaugh RK, Gross S, O'Hara SM, Smirnov DA, Terstappen LW, Allard WJ, Bilbee M, Cheng JD, Hoffman JP, Lewis NL, Pellegrino A, Rogatko A, Sigurdson E, Wang H, Watson JC, Weiner LM, Meropol NJ: Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Clin Colorectal Cancer, 6: 125-132, 2006. (Pubitemid 44445747)
54. Mathur P, Wharton RQ, Jonas SK, Saini S, Allen-Mersh TG: Relationship between tumour vascularity and circulating cancer cells in patients with colorectal carcinoma. Eur J Surg Oncol, 27: 354-358, 2001. (Pubitemid 32624536)
55. Xu D, Li XF, Zheng S, Jiang WZ: Quantitative real-time RTPCR detection for CEA, CK20 and CK19 mRNA in peripheral blood of colorectal cancer patients. J Zhejiang Univ Sci B, 7: 445-451, 2006.
56. Taneja P, Maglic D, Kai F, Zhu S, Kendig RD, Fry EA, Inoue K: Classical and novel prognostic markers for breast cancer and their clinical significance. Clin Med Insights, 4: 15-34, 2010.